Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Common Equity: 2020

Historic Common Equity for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2020 value amounting to $654,859.

  • Bright Minds Biosciences' Common Equity was N/A to $22.2 million in Q2 2021 from the same period last year, while for Jun 2021 it was $22.2 million, marking a year-over-year change of. This contributed to the annual value of $654,859 for FY2020, which is N/A change from last year.
  • Bright Minds Biosciences' Common Equity amounted to $654,859 in FY2020.
  • In the past 5 years, Bright Minds Biosciences' Common Equity registered a high of $654,859 during FY2020, and its lowest value of $654,859 during FY2020.
  • Its 1-year average for Common Equity is $654,859, with a median of $654,859 in 2020.